Troilus Announces Upsized $28 Million Bought Deal Offering
September 24, 2024 11:58 ET
|
Troilus Gold Corp.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX:...
GL Automates T1, E1 and Datacom Testing with Python Scripting Support
September 24, 2024 11:55 ET
|
GL Communications, Inc.
GL Communications automates T1, E1, and Datacom testing with tProbe™, enabling Python scripting, remote operations, and efficient protocol emulation.
LVMH: Share transactions disclosure
September 24, 2024 11:50 ET
|
LVMH
Paris, September 24th, 2024 The disclosure of share transactions carried out from September 16th to September 20th, 2024 was sent to the AMF on September 24th, 2024. As required by current law, this...
Carbeeza Inc. Announces Convertible Debenture Offering
September 24, 2024 11:48 ET
|
Carbeeza Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./ ...
Societe Generale: shares and voting rights as of 23 September 2024
September 24, 2024 11:48 ET
|
Société Générale
NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 23 SEPTEMBER 2024 Regulated Information Paris, 24 September 2024 Information about the total number of...
GALIMMO - Communiqué normé de la Note en réponse
September 24, 2024 11:47 ET
|
GALIMMO
COMMUNIQUÉ DE PRESSE EN DATE DU 24 SEPTEMBRE 2024 GALIMMO SCA OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE VISANT LES ACTIONS DE LA SOCIÉTÉ GALIMMO SCA SUIVIE D’UN RETRAIT OBLIGATOIRE Initiée...
LUMIBIRD: FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISION
September 24, 2024 11:45 ET
|
Lumibird SA
Lannion, September 24, 2024 – 17:45 pm FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISION EBITDA1 of €10.9m on a reported basis, compared with €13.8m in H1 2023...
Availability of Transgene’s Half-Year Financial Report as of June 30, 2024
September 24, 2024 11:45 ET
|
Transgene S.A.
TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2024. The...
Transgene to Report Major Clinical Data before the end of 2024 – Confirmed Financial Visibility until Q4 2025
September 24, 2024 11:45 ET
|
Transgene S.A.
2024 Half-Year Results and Business Update Lead program TG4050 (individualized immunotherapy): – First signs of clinical benefit in adjuvant head and neck cancer reported at AACR 2024,...
2024 Half-Year Financial Report
September 24, 2024 11:45 ET
|
Transgene S.A.
2024 Half Year Financial Report
Attachment
TRANSGENE_HALF-YEAR-FINANCIAL-REPORT-2024_EN
...